<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ep-patent-document PUBLIC "-//EPO//EP PATENT DOCUMENT 1.4//EN" "ep-patent-document-v1-4.dtd">
<ep-patent-document id="EP09015563B8W1" file="EP09015563W1B8.xml" lang="en" country="EP" doc-number="2233135" kind="B8" correction-code="W1" date-publ="20130710" status="c" dtd-version="ep-patent-document-v1-4">
<SDOBI lang="en"><B000><eptags><B001EP>ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSKBAHRIS..MTNORS......................</B001EP><B005EP>J</B005EP><B007EP>DIM360 Ver 2.40 (30 Jan 2013) -  2999001/0</B007EP><B070EP>The file contains technical information submitted after the application was filed and not included in this specification</B070EP><B078EP><date>20130328</date></B078EP></eptags></B000><B100><B110>2233135</B110><B120><B121>CORRECTED EUROPEAN PATENT SPECIFICATION</B121></B120><B130>B8</B130><B132EP>B1</B132EP><B140><date>20130710</date></B140><B150><B151>W1</B151><B153>72</B153><B155><B1551>de</B1551><B1552>Bibliographie</B1552><B1551>en</B1551><B1552>Bibliography</B1552><B1551>fr</B1551><B1552>Bibliographie</B1552></B155></B150><B190>EP</B190></B100><B200><B210>09015563.1</B210><B220><date>20081016</date></B220><B240><B241><date>20091216</date></B241><B242><date>20111026</date></B242></B240><B250>en</B250><B251EP>en</B251EP><B260>en</B260></B200><B300><B310>07291273</B310><B320><date>20071019</date></B320><B330><ctry>EP</ctry></B330><B310>989507 P</B310><B320><date>20071121</date></B320><B330><ctry>US</ctry></B330></B300><B400><B405><date>20130710</date><bnum>201328</bnum></B405><B430><date>20100929</date><bnum>201039</bnum></B430><B450><date>20120627</date><bnum>201226</bnum></B450><B452EP><date>20120127</date></B452EP><B480><date>20130710</date><bnum>201328</bnum></B480></B400><B500><B510EP><classification-ipcr sequence="1"><text>A61K  31/00        20060101AFI20100805BHEP        </text></classification-ipcr><classification-ipcr sequence="2"><text>A61K  31/138       20060101ALI20100805BHEP        </text></classification-ipcr><classification-ipcr sequence="3"><text>A61K  31/18        20060101ALI20100805BHEP        </text></classification-ipcr><classification-ipcr sequence="4"><text>A61K  31/222       20060101ALI20100805BHEP        </text></classification-ipcr><classification-ipcr sequence="5"><text>A61K  31/404       20060101ALI20100805BHEP        </text></classification-ipcr><classification-ipcr sequence="6"><text>A61K  31/4045      20060101ALI20100805BHEP        </text></classification-ipcr><classification-ipcr sequence="7"><text>A61K  31/4704      20060101ALI20100805BHEP        </text></classification-ipcr><classification-ipcr sequence="8"><text>A61K  31/5377      20060101ALI20100805BHEP        </text></classification-ipcr><classification-ipcr sequence="9"><text>A61K  31/36        20060101ALI20100805BHEP        </text></classification-ipcr><classification-ipcr sequence="10"><text>A61P  35/00        20060101ALI20100805BHEP        </text></classification-ipcr></B510EP><B540><B541>de</B541><B542>Verwendung von Beta-blockern für die Herstellung eines Medikaments zur Behandlung von Hämangiomen</B542><B541>en</B541><B542>Use of a beta blocker for the manufacture of a medicament for the treatment of hemangiomas</B542><B541>fr</B541><B542>Utilisation de bêtabloquants pour la fabrication d'un médicament pour le traitement d'hémangiomes</B542></B540><B560><B561><text>WO-A-97/40830</text></B561><B561><text>WO-A-2006/015830</text></B561><B561><text>WO-A1-2006/122007</text></B561><B562><text>AH-FAT F G ET AL: "Recurrent visual loss secondary to an iris microhaemangioma [1]" EYE 1994 GB, vol. 8, no. 3, 1994, page 357, XP008089190 ISSN: 0950-222X</text></B562><B562><text>GOODFIELD M J ET AL: "The clinical presentation of cutaneous angiolipomata and the response to beta-blockade." CLINICAL AND EXPERIMENTAL DERMATOLOGY MAY 1988, vol. 13, no. 3, May 1988 (1988-05), pages 190-192, XP008089157 ISSN: 0307-6938</text></B562><B562><text>BREM H ET AL: "The combination of antiangiogenic agents to inhibit primary tumor growth and metastasis" JOURNAL OF PEDIATRIC SURGERY 1993 US, vol. 28, no. 10, 1993, pages 1253-1257, XP002473031 ISSN: 0022-3468</text></B562><B562><text>PAPATHANASSIU, ADONIA E.: "Novel inhibitors of angiogenesis and their mechanism(s) of action" 158 PP. AVAIL.: UMI, ORDER NO. DA9828828 FROM: DISS. ABSTR. INT., B 1998, 59(4), 1454, 1998, XP008089194</text></B562><B562><text>LUTGENDORF SUSAN K ET AL: "Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines." CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH 1 OCT 2003 LNKD- PUBMED:14555525, vol. 9, no. 12, 1 October 2003 (2003-10-01), pages 4514-4521, XP002590205 ISSN: 1078-0432</text></B562><B562><text>THAKER PREMAL H ET AL: "Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma" NATURE MEDICINE, vol. 12, no. 8, August 2006 (2006-08), pages 939-944, XP002590206 ISSN: 1078-8956</text></B562><B562><text>RAZON MARIA J ET AL: "Increased apoptosis coincides with onset of involution in infantile hemangioma" MICROCIRCULATION (PHILADELPHIA), vol. 5, no. 2-3, September 1998 (1998-09), pages 189-195, XP002590207 ISSN: 1073-9688</text></B562><B562><text>SMITH SALLY K SOMMERS ET AL: "Beta blockade induces apoptosis in cultured capillary endothelial cells" IN VITRO CELLULAR AND DEVELOPMENTAL BIOLOGY ANIMAL, vol. 38, no. 5, May 2002 (2002-05), pages 298-304, XP002590208 ISSN: 1071-2690</text></B562><B562><text>BAGHESTANIAN M: "The role of beta-adrenergic blockers as antihypertensive medication in patients with peripheral arterial disease" ZEITSCHRIFT FUR GEFASSMEDIZIN 2006 AT, vol. 3, no. 2, 2006, pages 11-16, XP002590209</text></B562><B562><text>LÉAUTÉ-LABRÈZE CHRISTINE ET AL: "Propranolol for severe hemangiomas of infancy." 12 June 2008 (2008-06-12), THE NEW ENGLAND JOURNAL OF MEDICINE 12 JUN 2008, VOL. 358, NR. 24, PAGE(S) 2649 - 2651 , XP002523408 ISSN: 1533-4406 * the whole document *</text></B562><B562><text>BONIFAZI E ET AL: "Propranolol in rapidly growing hemangiomas" 2008, EUROPEAN JOURNAL OF PEDIATRIC DERMATOLOGY 2008 IT, VOL. 18, NR. 3, PAGE(S) 185 - 192 , XP008105082 ISSN: 1122-7672 * abstract * * page 185, column 1, paragraph 2 - page 186, column 2, paragraph 2l * * page 186 * * page 192, column 1, paragraph 1 - column 2, paragraph 1 *</text></B562><B562><text>CREMER H -J: "Propranolol: A milestone in the treatment of problematic hemangiomas?" October 2008 (2008-10), MONATSSCHRIFT FUR KINDERHEILKUNDE 200810 DE, VOL. 156, NR. 10, PAGE(S) 942 - 943 , XP002523410 ISSN: 0026-9298 * page 942 *</text></B562><B562><text>LEAUTE-LABREZE C ET AL: "Efficacy of beta-blockers in infantile capillary haemangiomas: The physiopathological significance and therapeutic consequences" December 2008 (2008-12), ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, VOL. 135, NR. 12, PAGE(S) 860-862 , XP008105076 ISSN: 0151-9638 * page 860 - page 861, column 1, last paragraph *</text></B562><B562><text>BLANCHET CATHERINE ET AL: "Management of infantile subglottic hemangioma: acebutolol or propranolol?", INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY AUG 2010 LNKD- PUBMED:20557953, vol. 74, no. 8, August 2010 (2010-08), pages 959-961, ISSN: 1872-8464</text></B562><B562><text>POPE ELENA ET AL: "Topical timolol gel for infantile hemangiomas: a pilot study.", ARCHIVES OF DERMATOLOGY MAY 2010 LNKD- PUBMED:20479314, vol. 146, no. 5, May 2010 (2010-05), pages 564-565, ISSN: 1538-3652</text></B562><B562><text>AKRAM I ET AL: "Iris microhaemangioma presenting with total hyphaema and elevated intraocular pressure.", EYE (BASINGSTOKE), vol. 17, no. 6, August 2003 (2003-08), pages 784-785, ISSN: 0950-222X</text></B562><B562><text>KHAN ZIA A ET AL: "Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice", JOURNAL OF CLINICAL INVESTIGATION, vol. 118, no. 7, July 2008 (2008-07), pages 2592-2599, ISSN: 0021-9738</text></B562><B562><text>RITTER MATTHEW R ET AL: "Pathogenesis of infantile haemangioma: new molecular and cellular insights", EXPERT REVIEWS IN MOLECULAR MEDICINE, vol. 9, no. 32, November 2007 (2007-11), ISSN: 1462-3994</text></B562><B562><text>SUNDINE MICHAEL J ET AL: "Hemangiomas: an overview.", CLINICAL PEDIATRICS APR 2007 LNKD- PUBMED:17416876, vol. 46, no. 3, April 2007 (2007-04), pages 206-221, ISSN: 0009-9228</text></B562><B562><text>FITZGERALD PAUL J: "Testing whether drugs that weaken norepinephrine signaling prevent or treat various types of cancer.", CLINICAL EPIDEMIOLOGY 2010 LNKD- PUBMED:20865096, vol. 2, 2010, pages 1-3, ISSN: 1179-1349</text></B562><B562><text>Orfanos Garbe: "Therapie der Hautkrankheiten", 2002, Springer-Verlag, Berlin pages 717-718,</text></B562><B562><text>GOODFIELD M J D ET AL: "The clinical presentation of cutaneous angiolipomata and the response to beta-blockade", CLINICAL AND EXPERIMENTAL DERMATOLOGY, BLACKWELL SCIENTIFIC PUBLICATIONS, GB, vol. 13, no. 3, 1 January 1988 (1988-01-01), pages 190-192, XP008089157, ISSN: 0307-6938, DOI: 10.1111/J.1365-2230.1988.TB01968.X</text></B562></B560></B500><B600><B620><parent><pdoc><dnum><anum>08838691.7</anum><pnum>2187878</pnum></dnum><date>20081016</date></pdoc></parent></B620></B600><B700><B720><B721><snm>Léauté-Labréze, Christine</snm><adr><str>8, Rue des Palombes</str><city>33185 Le Haillan</city><ctry>FR</ctry></adr></B721><B721><snm>Dumas de la Roque, Éric</snm><adr><str>4 rue du Capitaine Gilles</str><city>33140 Villenave d'Ornon</city><ctry>FR</ctry></adr></B721><B721><snm>Taieb, Alain</snm><adr><str>2 rue Lenôtre</str><city>33000 Bordeaux</city><ctry>FR</ctry></adr></B721><B721><snm>Thambo, Jean-Benoit</snm><adr><str>15 rue de Strasbourg</str><city>33000 Bordeaux</city><ctry>FR</ctry></adr></B721></B720><B730><B731><snm>Université Bordeaux Segalen</snm><iid>101251005</iid><irf>BIP132335EP01</irf><adr><str>146, rue Léo Saignat</str><city>33076 Bordeaux Cedex</city><ctry>FR</ctry></adr><B736EP><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B736EP></B731><B731><snm>Centre Hospitalier Universitaire de Bordeaux</snm><iid>101243462</iid><irf>BIP132335EP01</irf><adr><str>12 rue Dubernat</str><city>33404 Talence</city><ctry>FR</ctry></adr></B731></B730><B740><B741><snm>Novagraaf Technologies</snm><iid>100061566</iid><adr><str>122 rue Edouard Vaillant</str><city>92593 Levallois-Perret Cedex</city><ctry>FR</ctry></adr></B741></B740><B790><B791><dnum><text>0101</text></dnum><date>20120614</date><kind>E</kind><snm>Pierre Fabre Dermatologie</snm><iid>101318688</iid><adr><str>45 place Abel Gance</str><city>92100 Boulogne</city><ctry>FR</ctry></adr><B796><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B796></B791></B790></B700><B800><B840><ctry>AT</ctry><ctry>BE</ctry><ctry>BG</ctry><ctry>CH</ctry><ctry>CY</ctry><ctry>CZ</ctry><ctry>DE</ctry><ctry>DK</ctry><ctry>EE</ctry><ctry>ES</ctry><ctry>FI</ctry><ctry>FR</ctry><ctry>GB</ctry><ctry>GR</ctry><ctry>HR</ctry><ctry>HU</ctry><ctry>IE</ctry><ctry>IS</ctry><ctry>IT</ctry><ctry>LI</ctry><ctry>LT</ctry><ctry>LU</ctry><ctry>LV</ctry><ctry>MC</ctry><ctry>MT</ctry><ctry>NL</ctry><ctry>NO</ctry><ctry>PL</ctry><ctry>PT</ctry><ctry>RO</ctry><ctry>SE</ctry><ctry>SI</ctry><ctry>SK</ctry><ctry>TR</ctry></B840><B844EP><B845EP><ctry>AL</ctry><date>20091216</date></B845EP><B845EP><ctry>BA</ctry><date>20091216</date></B845EP><B845EP><ctry>MK</ctry><date>20100104</date></B845EP><B845EP><ctry>RS</ctry><date>20091216</date></B845EP></B844EP><B880><date>20100929</date><bnum>201039</bnum></B880></B800></SDOBI>
</ep-patent-document>
